Drug profile · INN
imlunestrant
INLURIYO
imlunestrant (INLURIYO) is an FDA-listed pharmaceutical active ingredient.
EMA: approved Antineoplastic and immunomodulating agents (L02) L02BA
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — imlunestrant
- Class
- Antineoplastic and immunomodulating agents (L02)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
imlunestrant (INLURIYO) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN imlunestrant
Brand INLURIYO
Therapeutic class Antineoplastic and immunomodulating agents (L02)
ATC code L02BA
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is imlunestrant?
imlunestrant (INLURIYO) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for imlunestrant?
INLURIYO is a marketed brand name for imlunestrant. Check FDA Drugs@FDA for the current US label holder and prescribing information.